Tabula Rasa HealthCare (TRHC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tabula Rasa Healthcare (TRHC ) PT Raised to $20 at Piper Jaffray
August 8, 2017 8:25 AM EDTPiper Jaffray raised its price target on Tabula Rasa Healthcare (NASDAQ: TRHC ) to $20.00 (from $19.00) while maintaining a Overweight rating following another strong quarter with upside to revenue and profitability.
Analyst Sean Wieland said they are encouraged by three contracts that remain on track to drive a step-up in... More
